Press Releases

Alfa Chemistry Updates: Website Refreshed and Product Offerings Optimized

Alfa Chemistry recently announces that it has refreshed its website and at the same time optimized its product offerings for customers across the globe. The company has long been known as a chemical vendor among the research and industrial community, supplying a full range of high quality chemicals such as lipids, material & chemicals, metal organics, nanomaterials, surfactant and more.

Bio-Gate expands customer base for antiviral and antibacterial products

Qvirus Platform Released Oncolytic Vesicular Stomatitis Virus Service For Virus-related Project

CUREBASE UNLOCKS DRUG DEVELOPMENT WITH REMOTE CLINICAL TRIALS; RAISES $15M LED BY GGV CAPITAL

Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial software platform and virtual research site capabilities.

IntegrateRNA Offers High-quality Oligonucleotide Conjuagted Services to Facilitate Diagnostic And Targeted Drug Delivery

Alfa Chemistry Materials Presents Carbon Nanotubes and Graphene with High Quality on its Website

The past decade has witnessed an increasing demand for novel materials such as carbon nanotubes and graphenes. To facilitate researcher’s purchase of novel material chemicals, Alfa Chemistry Materials, a material subsidiary of Alfa Chemistry, recently announces that both carbon nanotubes and graphenes with high quality are now presented as main featured products on its website.

Creative Biostructure Established Various Systems for Protein Expression in Pharmaceutical Field

Creative BioMart Biomarker Provides a Variety of Platforms for Imaging Biomarker Detection

Matexcel Provides Professional Product Analysis Services to Meet Evolving Demands

Lifeasible Provides a Full Range of Methods for Phytochemical Tests

WCG IRB Welcomes 2021 Class to International Fellows Program on Research Ethics

This annual program builds upon WCG IRB’s expertise and 50-year legacy of global service, protecting the safety of clinical trial participants, and preserving the scientific integrity of research protocols. The 2021 program offers virtual training globally, continuing efforts to improve IRB operations worldwide and educate the next generation of research leaders amid the COVID-19 pandemic.

Mission of Protheragen MedAI: to Seek Innovative Solutions for Drug Discovery and Life Science Research

CD Formulation Is Able to Conduct API-Excipient Compatibility Analysis

Protheragen MedAI Releases Protein Structure Modeling Service

eClinical Solutions to Showcase Data Strategies for Digital and Decentralized Trials at PHUSE, DIA and Other Key Industry Events

Mansfield, MA, May 27, 2021 — eClinical Solutions LLC, a global provider of cloud-based enterprise software and software-driven clinical data services that accelerate digital clinical initiatives, today announced that their thought leaders will be participating in a variety of industry events this spring to discuss the impact of data on future clinical trials. As data sources increase due to the demands for decentralized and patient-centric trials, sponsors and CROs are experiencing longer timelines for clinical data review, management and analyses.

eClinical Solutions Shares Business Strategies for Accelerated Clinical Trials Post Covid-19

eClinical thought leaders to discuss decentralized trials, digital transformation of clinical research and modernized clinical data infrastructures at upcoming industry events

Crucial Data Solutions and SISCAPA Assay Technologies Partner to Introduce a New Approach to Diagnostics and Remote Health Monitoring

Together, CDS and SAT are leveraging the latest mobile and wearable technologies to achieve remote, longitudinal tracking of biomarkers in clinical trials

BOC Sciences Provides Extensive Catalog of Isotope Labeled Products

TRIO Partners with eClinical Solutions to Power Digital Transformation in Clinical Trials for Cancer

Global clinical research organization selects eClinical’s elluminate clinical data platform to optimize trial efficiency and speed

ComputaBio Has Launched Molecular Dynamics Simulation Services for Drug R&D Projects

ComputaBio, a US supplier of professional computational biology services, has launched molecular dynamics simulation services for industrial and academic customers to expedite the process of drug design.